G1 Therapeutics announces positive topline results from phase II trial of trilaciclib in SCLC

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.

June 28, 2024

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.

June 28, 2024

Vol.50 No.26

By Matthew Bin Han Ong

White House

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Leaders of three health agencies presented new initiatives focused on patient-centered research, diversity in clinical trial enrollment, and innovation in clinical research.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

Obituary

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

Edward Sondik, an electrical engineer by training, followed a career path that led him to top public health positions.He was a director of the National Center for Health Statistics at CDC, an acting director of NCI, and a deputy director of the NCI Division of Cancer Prevention and Control.

June 28, 2024

Vol.50 No.26

By Jacquelyn Cobb

BSA approves five new, 17 reissue concepts

The NCI Board of Scientific Advisors approved five new concepts and 17 reissue concepts at a joint meeting of the BSA and the National Cancer Advisory Board June 11-12.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

In the Archives

Edward Sondik on his beginnings in public health, cancer prevention, and a “battlefield promotion”

Edward Sondik, former director of the National Center for Health Statistics at CDC, who previously served as an acting director of NCI, and a deputy director of the NCI Division of Cancer Prevention and Control, died on June 25. He was 82.

June 28, 2024

Vol.50 No.26

G1 Therapeutics announces positive topline results from phase II trial of trilaciclib in SCLC

YOU MAY BE INTERESTED IN

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

BSA approves five new, 17 reissue concepts

Edward Sondik on his beginnings in public health, cancer prevention, and a “battlefield promotion”

Renew today!

Subscriber content

Login

G1 Therapeutics announces positive topline results from phase II trial of trilaciclib in SCLC

YOU MAY BE INTERESTED IN

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forwardNCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

BSA approves five new, 17 reissue concepts

Edward Sondik on his beginnings in public health, cancer prevention, and a “battlefield promotion”

Login

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists